24239

0

MEDIORG

img img img img
No Data Available

MEDICAMEN ORGANICS LTD Share Price Update

As of the latest trading session, MEDICAMEN ORGANICS LTD is trading at ₹21.1, down by ₹-0.50 or -2.31% from its previous close. The stock has moved between ₹19.50 and ₹21.80 today. Over the past year, the stock has delivered a return of -46.73%. In the last month, it has returned -26.02%.

MEDICAMEN ORGANICS LTD performance

Today’s low Today’s high
₹ 19.50 ₹ 21.80
₹ 21.80
52 week low 52 week high
₹ 19.50 ₹ 49.70
₹ 21.80
Open Price ₹ 20.05
Prev. Close ₹ 21.60
Volume (Shares) 44000.00
Total traded value ₹ 9.59
Upper Circuit ₹ 23.75
Lower Circuit ₹ 19.45
info

Investment Returns

Over 1 Month -26.02% Over 3 Months -5.26% Over 6 Months -23.80% Over 1 Year -46.73%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

MEDICAMEN ORGANICS LTD fundamentals


  • Market cap (Cr) 26.50
  • P/E Ratio (TTM) -8.64
  • Beta 0.96
  • Book Value / share 23.67
  • Return on equity 14.54%
  • EPS (TTM) 0.00
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 0.00
info icon alternate text
  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) [-]
info icon alternate text

MEDICAMEN ORGANICS LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 21.65
Operating Expense 26.03
Net Profit -3.05
Net Profit Margin (%) -14.08
Earnings Per Share (EPS) -2.58
EBITDA -2.69
Effective Tax Rate (%) 29.30
Particulars MAR 2025 (Values in Cr)
Revenue 37.09
Operating Expense 32.79
Net Profit 3.27
Net Profit Margin (%) 8.81
Earnings Per Share (EPS) 2.98
EBITDA 5.64
Effective Tax Rate (%) 25.51
Particulars MAR 2024 (Values in Cr)
Revenue 25.27
Operating Expense 21.90
Net Profit 2.62
Net Profit Margin (%) 10.36
Earnings Per Share (EPS) 3.47
EBITDA 5.81
Effective Tax Rate (%) 40.76
Particulars MAR 2023 (Values in Cr)
Revenue 22.15
Operating Expense 21.59
Net Profit 0.97
Net Profit Margin (%) 4.37
Earnings Per Share (EPS) 1.60
EBITDA 2.68
Effective Tax Rate (%) 28.67
Particulars MAR 2022 (Values in Cr)
Revenue 20.98
Operating Expense 20.93
Net Profit 0.09
Net Profit Margin (%) 0.42
Earnings Per Share (EPS) 0.15
EBITDA 1.41
Effective Tax Rate (%) 61.53
Particulars MAR 2025 (Values in Cr)
Book Value / Share 25.11
ROE % 17.85
ROCE % 16.85
Total Debt to Total Equity 0.55
EBITDA Margin 17.57
Particulars MAR 2024 (Values in Cr)
Book Value / Share 17.74
ROE % 13.11
ROCE % 14.33
Total Debt to Total Equity 0.83
EBITDA Margin 18.84
Particulars MAR 2025 (Values in Cr)
Book Value / Share 24.76
ROE % 14.54
ROCE % 14.04
Total Debt to Total Equity 0.55
EBITDA Margin 15.26
Particulars MAR 2024 (Values in Cr)
Book Value / Share 17.74
ROE % 16.50
ROCE % 16.41
Total Debt to Total Equity 1.01
EBITDA Margin 18.84
Particulars MAR 2023 (Values in Cr)
Book Value / Share 14.97
ROE % 11.73
ROCE % 10.09
Total Debt to Total Equity 1.33
EBITDA Margin 12.10
Particulars MAR 2022 (Values in Cr)
Book Value / Share 12.60
ROE % 1.20
ROCE % 4.08
Total Debt to Total Equity 1.32
EBITDA Margin 6.72
Particulars MAR 2021 (Values in Cr)
Book Value / Share 12.45
ROE % 4.12
ROCE % 5.92
Total Debt to Total Equity 1.23
EBITDA Margin 6.59
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 4.13
Total Assets 59.20
Total Liabilities 59.20
Total Equity 30.48
Share Outstanding 1
Price to Book Ratio 0.88
Return on Assets (%) 6.83
Return on Capital (%) 9.45
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.55
Total Assets 38.44
Total Liabilities 38.44
Total Equity 15.25
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 6.82
Return on Capital (%) 9.4
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 3.26
Total Assets 57.44
Total Liabilities 57.44
Total Equity 29.72
Share Outstanding 1
Price to Book Ratio 0.88
Return on Assets (%) 5.69
Return on Capital (%) 7.81
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.55
Total Assets 38.44
Total Liabilities 38.44
Total Equity 15.25
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 6.82
Return on Capital (%) 9.4
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.52
Total Assets 32.58
Total Liabilities 32.58
Total Equity 8.97
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 2.97
Return on Capital (%) 4.67
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.43
Total Assets 27.07
Total Liabilities 27.07
Total Equity 7.55
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 0.34
Return on Capital (%) 0.52
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.88
Total Assets 26.34
Total Liabilities 26.34
Total Equity 7.46
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 1.13
Return on Capital (%) 1.75
Particulars MAR 2025 (Values in Cr)
Net Income 5.43
Cash from Operations -4.44
Cash from Investing -2.35
Cash from Financing 10.47
Net change in Cash 3.57
Free Cash Flow -2.00
Particulars MAR 2024 (Values in Cr)
Net Income 3.38
Cash from Operations -3.48
Cash from Investing -0.33
Cash from Financing 4.01
Net change in Cash 0.01
Free Cash Flow -3.13
Particulars MAR 2025 (Values in Cr)
Net Income 4.38
Cash from Operations -4.81
Cash from Investing -2.62
Cash from Financing 10.25
Net change in Cash 2.71
Free Cash Flow -2.36
Particulars MAR 2024 (Values in Cr)
Net Income 3.38
Cash from Operations -3.48
Cash from Investing -0.33
Cash from Financing 4.01
Net change in Cash 0.01
Free Cash Flow -3.13
Particulars MAR 2023 (Values in Cr)
Net Income 1.35
Cash from Operations -0.53
Cash from Investing -0.28
Cash from Financing 0.93
Net change in Cash 0.07
Free Cash Flow -0.24
Particulars MAR 2022 (Values in Cr)
Net Income 0.25
Cash from Operations 0.10
Cash from Investing -0.59
Cash from Financing 0.18
Net change in Cash -0.37
Free Cash Flow 0.71
Particulars MAR 2021 (Values in Cr)
Net Income 0.49
Cash from Operations -1.11
Cash from Investing -0.01
Cash from Financing 1.26
Net change in Cash 0.09
Free Cash Flow -1.09
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.29 14.58 1.70 270.44 23.12 38.50
BLISS GVS PHARMA LTD. 402.00 32.52 3.56 4252.72 118.35 437.40
CIPLA LTD. 1390.85 27.54 3.26 112352.94 1165.55 1672.20
FERMENTA BIOTECH LIMITED 300.35 13.25 2.17 883.96 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 35.29 24.68 4.54 270.44 23.12 38.50
AMRUTANJAN HEALTH CARE LTD. 558.20 25.02 4.35 1613.79 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8724.25 113.94 24.98 21810.63 7630.00 10653.05
BLISS GVS PHARMA LTD. 402.00 43.23 3.68 4252.72 118.35 437.40

MEDICAMEN ORGANICS LTD shareholding pattern

Holding
38.56%
59.72%
0.06%
1.64%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

MEDICAMEN ORGANICS LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
21.80 0.92 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 23.50
  • 26 Days 25.80
  • 10 Days 24.60
  • 50 Days 25.90
  • 12 Days 24.90
  • 100 Days 26.60
  • 20 Days 25.60
  • 200 Days 31.00
21.67 PIVOT
First Support 21.53 First Resistance 21.73 Second Support 21.47 Second Resistance 21.87 Third Support 21.33 Third Resistance 21.93
RSI 28.15 ADX 27.94 MACD -0.94 Williams % R -100.00 Commodity Channel Index (CCI) -182.69
Date 2026-06-01 Week 28800.00 Same Day 114000.00 Month 17000.00
1 Year 0.97 3 Year 0.75
Over 1 Month
-26.02% down
Over 1 Year
-46.73% down
Over 3 Months
-5.26% down
Over 3 Years
0.00% down
Over 6 Months
-23.80% down
Over 5 Years
0.00% down

MEDICAMEN ORGANICS LTD Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Medicamen Organics Ltd?

Answer Field

Medicamen Organics Ltd share price is for NSE ₹ 21.10 & for BSE ₹ 0.00 as on Jun 02 2026 01:26 PM.

What is the Market Cap of Medicamen Organics Ltd Share?

Answer Field

The market cap of Medicamen Organics Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 02 2026 01:26 PM.

What is the 52 Week High and Low of Medicamen Organics Ltd?

Answer Field

The 52 Week High and Low of Medicamen Organics Ltd for NSE is ₹ 49.70 and ₹ 19.50 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Medicamen Organics Ltd?

Answer Field

The 1 year returns on the stock has been -46.73%.

What is the P/E Ratio of Medicamen Organics Ltd Share?

Answer Field

As on Jun 02 2026 01:26 PM the price-to-earnings (PE) ratio for Medicamen Organics Ltd share is -8.64.

What is the PB ratio of Medicamen Organics Ltd Share?

Answer Field

As on Jun 02 2026 01:26 PM, the price-to-book (PB) ratio for Medicamen Organics Ltd share is 23.67.

How to Buy Medicamen Organics Ltd Share?

Answer Field

You can trade in Medicamen Organics Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Medicamen Organics Ltd Share on Bajaj Broking App?

Answer Field

To buy Medicamen Organics Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Medicamen Organics Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|